Français
ItalianoBond Royalty Pharma 2.2% ( US78081BAD55 ) in USD
| Issuer | Royalty Pharma | ||||
| Market price |  100 % ▲ |
||||
| Country |  United States
|
||||
| ISIN code |
 US78081BAD55 ( in USD )
|
||||
| Interest rate | 2.2% per year ( payment 2 times a year) | ||||
| Maturity | 09/02/2030 | ||||
| Minimal amount | 2 000 USD | ||||
| Total amount | 1 000 000 000 USD | ||||
| Cusip | 78081BAD5 | ||||
| Standard & Poor's ( S&P ) rating | BBB ( Lower medium grade - Investment-grade ) | ||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||
| Next Coupon | 03/02/2027 ( In 128 days ) | ||||
| Detailed description |
Royalty Pharma is a biopharmaceutical company that invests in and manages royalties from marketed pharmaceutical and biotechnology products. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAD55, pays a coupon of 2.2% per year. The coupons are paid 2 times per year and the Bond maturity is 09/02/2030 The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAD55, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAD55, was rated BBB ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||